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Abstract: The current report contributes to the understanding of the stereoselectivity of chiral
dirhodium(II) carboxylate catalysts carrying N-protected tert-leucine ligands. Investigating the
possible effect of ligand stereo-purity on catalyst structure and enantioselectivity was carried out.
This was justified through a new X-ray crystal structure for Rh2(S,S,S,R-PTTL)4 diastereomer.
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crystallography; chiral catalysis; metal-carbene; phenyliodonium ylide
1. Introduction
Chiral dirhodium(II) complexes are currently renowned as catalysts that can effectively drive
a broad spectrum of reactions with superior levels of chemo-, regio- and stereo-selectivity [1–14].
Their remarkable selectivity has reached a stage where they can function as a powerful tool in building
up value added molecules with complex structures [7,15–34].
Out of the large dirhodium(II) catalyst family and by following different approaches for catalyst
design, several highly enantioselective dirhodium(II) carboxylate catalysts have been reported to
date [13,35–44]. Our research group, for example, has recently reported a novel approach for the
design of dirhodium(II) tetracarboxylate complexes derived from S-amino acid ligands [35,36,45].
This approach is founded on tailoring the steric influences of the overall catalyst structure through
reducing the local symmetry of the ligand’s N-heterocyclic tether. The application of this new approach
led to the uncovering of Rh2(S-tertPTTL)4 (Figure 1) as a new member to the dirhodium(II) family with
outstanding selectivity in asymmetric cyclopropanation reactions [35]. However, despite the number
of successful approaches used for catalyst design, limited evidence is still available on how the four
chiral carboxylate ligands within the dirhodium(II) carboxylate framework tailor the product chirality
at the catalyst active center [46].
At the heart of all enantioselectivities observed with chiral dirhodium(II) carboxylate complexes is,
of course, the individual chirality of ligands. In the case of published X-ray crystal structures of various
solvated adducts of Rh2(S-PTTL)4 [47,48], Rh2(S-tertPTTL)4 [35], Rh2(S-NTTL)4 [49], Rh2(S-PTAD)4 [35]
and others [35,50,51], the incorporation of a ligand stereogenic center begets a “chiral cavity“ or a
“chiral pocket”. Figure 2 [47,48] depicts the two most important features that are responsible for the
establishment of the chiral binding pocket in Rh2(S-PTTL)4 and related complexes; C–C bond torsion
(bond connecting carboxylate carbon to α-carbon) that is positioned so as to guide the C–N single
bond leading to a clockwise twist of the chiral cavity walls (Figure 2a), and C–N bond torsion (bond
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connecting α-carbon to nitrogen) so as to permit docking of neighboring N-phthaloyl units (featuring
alternating O...H–C closest contacts, Figure 2c). The overall visual result is that the eight oxygen atoms
of the ligands’ N-phthaloyl units are placed at alternate high and low positions around the periphery of
the carbene binding pocket (Figure 2b) [35]. Based on these observed features, the use of optically pure
ligands in the process of catalyst preparation is essential for the construction of the symmetric chiral
cavity and for achieving extremely reliable enantioselective catalysis [52]. This is because, the inclusion
































As a  consequence, Hashimoto  et al.  explored  the  racemization  free N‐phthaloylation of  tert‐
leucine  [53]. They reported  that minimal racemization can be achieved  in refluxing  toluene  in  the 
presence of triethylamine (TEA). Charette also reported that N‐protection of different L‐amino acids 
can be done in refluxing DMF to achieve the desired enantiomerically pure N‐protected‐L‐amino acid 
ligands  [41]. Likewise, N‐1,8‐  [41,54] and N‐2,3‐naphthaloylation  [55] of L‐amino acids were also 
reported to take place under the same reaction conditions. In both latter cases, the prepared ligands 
were  used  in  the  preparation  of  the  corresponding  dirhodium(II)  catalysts  for  enantioselective 
applications. Another report claimed that racemization free N‐protection of amino acids was possible 
in  refluxing  acetic  acid  [56].  These  later  reports  did  not,  however,  support  their  claims  by  any 
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Figure 2. (a) Features that contribute to the chirality nature of the carbene binding cavity of
Rh2(S-PTTL)4 and associated catalysts; (b) Schematic presentation of the daisy chain manner by
which the Rh2(S-PTTL)4 binding pocket is constructed (c) Space filling of mono-EtOAc adduct of
Rh2(S-PTTL)4 (top and side views) [35,47,48]. (Adapted from Adly, F.G.; Gardiner, M.G.; Ghanem, A.
Chem. Eur. J. 2016, 22, 3447, with permission from John Wiley and Sons, Hoboken, NJ, USA).
As a consequence, Hashimoto et al. explored the racemization free N-phthaloylation of
tert-leucine [53]. They reported that minimal racemization can be achieved in refluxing toluene
in the presence of triethylamine (TEA). Charette also reported that N-protection of different L-amino
acids can be done in refluxing DMF to achieve the desired enantiomerically pure N-protected-L-amino
acid ligands [41]. Likewise, N-1,8- [41,54] and N-2,3-naphthaloylation [55] of L-amino acids were
also reported to take place under the same reaction conditions. In both latter cases, the prepared
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ligands were used in the preparation of the corresponding dirhodium(II) catalysts for enantioselective
applications. Another report claimed that racemization free N-protection of amino acids was possible in
refluxing acetic acid [56]. These later reports did not, however, support their claims by any quantitative
information about the degree of racemization that accompanied the N-protection process under the
reported reaction conditions and minimal/no racemization was assumed to take place.
Now the questions are, what is the effect if ligand enantio-impurity is present on the chiral cavity
features explained earlier? and to what extent this impurity might affect the functionality of that cavity?
To the best of our knowledge, there are no published reports to indicate the issues/benefits that might
accompany the use of enantiomerically impure chiral ligand in the process of chiral dirhodium(II)
catalyst preparation. Therefore, the trigger of the current research was to point out any aspects that can
correlate the enantio-purity of the chiral carboxylate ligand used to the structure of the corresponding
catalyst and to highlight any implications that this might have on catalyst enantioselectivity. We
were inspired by the work done by Fox [40] and Charette [41], independently, as they both explored
the interruption of the chiral cavity symmetry by substituting one of the four carboxylate ligands
with an achiral ligand. Screening results revealed that interrupting the cavity framework has, indeed,
a beneficial impact on the asymmetric induction of these complexes.
2. Results and Discussion
The current work started when PTTL ligand was synthesised three times using three different
reaction solvents namely acetic acid, DMF and toluene/TEA, under refluxing conditions leading to
chiral ligands with different degrees of enantiopurity (ee values of the obtained PTTL ligands from
acetic acid, DMF and toluene/TEA solvents were found to be 78%, 86% and >99% ee, respectively).
These prepared ligands were further used for the synthesis of three dirhodium(II) complexes,
Rh2(PTTL78%ee)4, Rh2(PTTL86%ee)4 and Rh2(PTTL99%ee)4, respectively at which, the obtained complexes
were expected to vary in their degree of stereo-purity.
When Rh2(PTTL78%ee)4 was crystallized from methanol/water in an open flask, two types of
X-ray quality crystals were observed and isolated. The first were green prismatic crystals and,
they were found to have the composition of [Rh2(S-PTTL)4.(H2O)][Rh2(S-PTTL)4.2(H2O)].5H2O
by X-ray crystal structure determination (Figure 3a,b). Although the complex molecules are still
retaining the chiral crown cavity of approximate C4 symmetry similar to the regular cavity structure of
[Rh2(S-PTTL)4.(EtOAc)] [47,48], the inherent weakness of the cavity walls is apparent in the obtained
aquated Rh2(S-PTTL)4 structure(s) (Figure 3a,b). This is owing to the obvious absence of strong
interactions between adjacent N-phthaloyl units.
In fact, there are several structural features of major significance that comes to light through the
detailed analysis of this newly determined X-ray structure of Rh2(PTTL)4 which can be correlated to
the performance of this class of dirhodium(II) complexes in asymmetric catalysis. From the current
structure and in light of the recent advances in the field, it is evident that the previously reported
flattened rectangular shape structure of the crown cavity [47,48] is subject to substantial variations
which appear to be influenced by the identity of the axial bound ligand and, at least in the solid
state, by the intermolecular interactions including crystal packing forces. Whilst of irregular shape,
the crown cavity of the current structure(s) (Figure 3a,b) can be described as being quite square shaped
of ca. 13–14 Å width if compared to the rectangular shaped cavity reported for [Rh2(S-PTTL)4.(EtOAc)]
(12.8 x 14.1 Å) [47,48].
Beyond the overall shape of the irregular crown cavities described above, the mono aquated
complex, [Rh2(S-PTTL)4.(H2O)], features a partial “reversal” of its chiral nature (Figure 3a). Whilst
all four ligands maintain their S-stereogenic carbon centres, the C–N bond from this carbon centre
in one ligand is close to being aligned with the axial coordination site of the Rh centre (circled in
Figure 3a). This is in contrast with the clockwise twist reported for [Rh2(S-PTTL)4.(EtOAc)] [47,48]
and other related complexes [35,49–51]. As a result, the daisy-chain type docking of the N-phthaloyl
units around the cavity seen in [Rh2(S-PTTL)4.(EtOAc)], which gives the cavity its main chiral feature
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(Figure 2c), is not only disrupted but is, in fact, partially reversed. This was most apparent in the
formation of an edge (C–H)-face pi-stacking of the involved N-phthaloyl unit with an adjacent ligand
and a partial loss in regularity of the alternating locations of the oxygen atoms around the cavity
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Figure 3. Space filling and schematic representations of the irregularly shaped chiral crown cavities of;
(a) [Rh2(S-PTTL)4.(H2O)] and (b) [Rh2(S-PTTL)4.2(H2O)]. Rh bound and lattice water molecules are
depicted in stick form (hydrogen atoms of all water molecules could not be located and the extended
hydrogen bonded structure is not shown beyond the asymmetric unit). Also shown in stick form
are the endo-cavity residing N-phthaloyl units of the adjacent crystallographically distinct complex
featuring face-to-face pi-stacking interactions. A side view into the equatorial plane of the Rh centers is
given in (a) to highlight the significantly different conformation of one of the ligands that results in
“reversal” of the chirality of the crown cavity.
On the other hand, when Rh2(PTTL78%ee)4 was crystallized from anhydrous methanol under argon
atmosphere, we were able to isolate crystals of a methanol solvated adduct and determine the X-ray
crystal structure. The observed structure was different to the one crystallized from methanol/water.
This showed the complex to be the di-solvated species [Rh2(S-PTTL)4.(MeOH)2].(MeOH)3/2.
This complex exhibited a distorted crown cavity where one of the N-heterocycles features a reverse
twist akin to the mono-aquated adduct [Rh2(S-PTTL)4.(H2O)] described above. In the solid state,
there are two crystallographically independent molecules each having this structure, despite having
different endo-cavity arrangements of hydrogen bonded MeOH molecules in addition to the axially
coordinated solvent.
The ability of Rh2(S-PTTL)4 to have axial ligands bonded to the Rh centre shrouded by the
crown cavity, as well as the more sterically encumbered Rh centre was, indeed, evident through the
obtained di-aquated structure (Figure 3b). This fact was also previously observed through many
other complexes from the same family [35,49–51] including Rh2(S-PTAD)4 which carry the bulkiest
adamantyl groups at the ligands’ α-positions [35]. This observation can be also applied to carbene
ligands during asymmetric catalysis which contradicts with the major assumption of Fox mechanistic
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study for Rh2(S-PTTL)4 in asymmetric cyclopropanations [47,48]. Fox assumed that only the Rh centre
within the chiral crown cavity is accessible by the incoming substrate while the other is shielded by
the four tert-butyl substituents of the PTTL ligands. This prior held assumption may not be valid and
should be revised.
In addition to the aquated form of Rh2(S-PTTL)4 described above, we succeeded to identify
another plate shaped green crystalline form from our methanol/water crystallized sample of
Rh2(PTTL78%ee)4. These crystals were shown to be comprised of the catalyst diastereomeric form,
[Rh2(S,S,S,R-PTTL)4(MeOH)2.].MeOH.H2O (Figure 4) by X-ray structure determination.Catalysts 2018, 8, x FOR PEER REVIEW    5 of 14 
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Figure 4. Space filling and schematic representations of the partial crown shaped chiral cavity of
[Rh2(S,S,S,R-PTTL)4(MeOH)2].MeOH.H2O viewed along the Rh-Rh bond (a) onto the cavity and (c)
from the opposite side of the cavity. (b) A side view into the equatorial plane of the Rh centres to
highlight the R-amino acid derived ligand which does not form part of the partial cavity. Rh bound
MeOH and lattice MeOH/water molecules are depicted in stick form (hydroxyl groups of the Lewis
bases were only located if Rh bound and the extended hydrogen bonded structure is not shown beyond
the asymmetric unit).
In addition to identifying at least one of the forms in which the R-amino acid impurity manifests
itself, an analysis of the structural details is also instructive here as it allows speculation s to the
possible enantioselectivity t at this impurity would achieve under catalytic conditions. This analysis is
of m jor i portance if the level of impurity is significant. The S,S,S,R- form features Rh bound
methanol molecules at e ch axial c ordination site an an α,α,α,β-conformation of the lig nds,
whereby the three N- phthaloyl units of the S-amino acid derived ligands form a partial crown
cavity and the unique R- min acid deriv d ligand faces the other axial binding site. Two of the
N-phthaloyl groups forming the partial crown cavity exhibit conformations very similar to those
in [Rh2(S-PTTL)4(EtOAc)] [47,48] an the pred minant ligand types found in the aquated species
describ d above (circle in Figure 4 ). The third N-phthaloyl unit lacks the clockwise twist noted
previously. This overall motif affords a partial cavity chirality (shown schematically in Figure 4a) of the
same nature to the enantiomerically pure S,S,S,S- diastereomer of th complex (shown schematically
in Figure 2). Based on previous results from Fox [40] and Charette [41] related to the functionality
of th α,α,α,β-conformation, it can be hypothesized that the obt in d S,S,S,R- form may still achiev
a good degree of enantioselectivity and, importantly, towards the same product as obtained with
the domi ant S,S,S,S- form. Whilst we cannot disprove the presence of further diastereomeric forms
Catalysts 2018, 8, 268 6 of 15
existing in the same sample of Rh2(PTTL78%ee)4 at this stage, we have highlighted the potential
advantage of the enantiomeric ligand purity assimilating as a minor component within the S,S,S,R-
diastereomeric form rather than segregating as the R,R,R,R- enantiomer which will strictly afford the
opposite enantioselectivity to the S,S,S,S- form.
At this stage and based on the obtained X-ray crystal structures, we decided to establish if the
S,S,S,R- diastereomeric form of the catalyst is still functional and can lead in high enantioselectivity.
we made use of the powerful method of asymmetric amplification by nonlinear effects. If the
catalyst system contains a non-enantiopure chiral ligand with an enantiomeric excess eeligand,
an enantiomerically enriched product with an enantiomeric excess of eeprod can be obtained.
The calculation of the enantiomeric excess of the product (eemax) for an enantiopure ligand can easily
be calculated if one assumes that the enantiomers of the ligand (in the catalyst) act independently.
The proportionality between eeligand and eeprod in the below equation allows the eemax value to be
calculated (ee values between 0 and 1). In other words, the expected enantiomeric excess of the reaction
product should be proportional to the ee value of the chiral ligand in the catalyst (Linearity). However,
in the case of multi-ligated catalysts (which is the case of chiral dirhodium(II) tetracarboxylate catalysts),
the above equation generally is no longer obeyed. This is because diastereomeric species are produced
which are impossible to generate from the enantiopure ligands. In fact, some deviation from linearity
may be observed (non-Linear effect) [52].
eeProd(%) = eemax·eeligand·100
In addition to the three prepared versions of Rh2(PTTL)4, five more dirhodium(II) complexes
were prepared of which each complex was prepared three times using ligands obtained from acetic
acid, DMF and toluene/TEA as reaction solvents (Schemes 1 and 2). Scheme 1 illustrates the extent of
racemization in the prepared N-protected amino acid ligands by just changing the reaction solvent.
It was obvious from HPLC trace that different degrees of racemization were introduced by changing
the reaction conditions. It was clear that accessing ligands with minimal racemization can be readily
accomplished by using toluene/TEA as a reaction solvent. This result is in agreement with the previous
report by Hashimoto et al. for the preparation of the PTTL ligand [53]. By the application of this
reaction conditions, the racemization degree in the prepared N-protected amino acids is restricted and
kept to minimal. An exception to this was the case of N-1,2-naphthaloyl phenylalanine (1,2-NTPA),
at which around 15% racemization took place (Scheme 1).
At this point, all the prepared catalysts were subjected to catalysis and to facilitate the investigation,
we employed our previously developed user-friendly one-pot cyclopropanation reaction of styrene in
the presence of Meldrum’s acid. In this reaction, a phenyliodonium ylide is generated and used in
situ [54,57]. All reactions were done at room temperature in DCM as reaction solvent.
In general, the cyclopropane product was generated in moderate isolated yields for all catalysts
(45–60% yield) except for Rh2(S-1,2-NTTR)4 and Rh2(S-1,2-NTTY)4 (18% and 14%, respectively)
and the obtained values were reproducible for all catalyst versions. The low yield observed with
Rh2(S-1,2-NTTR)4 was returned to the poor solubility of the catalyst in reaction solvent. On the
other hand, the low yield with Rh2(S-1,2-NTTY)4 was returned to the possible formation of a catalyst
polymeric structure in solution at which some of the p-OH groups of the –CH2C6H4–OH substituents
of one complex molecule might act as the axial ligands on each Rh centre of adjacent complex molecules
to block both catalyst’s active sites and inhibits the catalyst from being functional [58]. In both cases,
low conversion to product was observed.
In terms of catalyst enantioselectivity, results are illustrated in Figure 5. As expected, the obtained
results for this study, graphically depicted in Figure 5, clearly revealed a modest but real, positive
nonlinear effect for Rh2(PTTL)4, Rh2(1,2-NTTL)4, Rh2(1,2-NTPA)4 and Rh2(1,2-NTLU)4 catalysts.
The results suggested that diastereomeric species with a partial crown structure similar to the S,S,S,R-
diastereomer observed for Rh2(PTTL)4 might be still functional and can lead to enantioselectivity
levels similar to the full crown structures.
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Scheme 1. Effect of varying the reaction solvent on enantiomeric purity of the obtained N-protected
amino acid ligands. Enantiomeric excess percentages (ee%) were determined by chiral HPLC using (a)
Chiralpak® IB column, (b) Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with 0.1% TFA,
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Scheme 2. Preparation and structure of dirhodium(II) complexes.
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Figure 5. Effect of ligand enantio-purity on the enantioselectivity of its corresponding dirhodium(II)
catalyst.
On the other side, Rh2(1,2-NTTR)4 and Rh2(1,2-NTTY)4 showed negative deviation from linearity.
In these particular cases, other solution species may have arisen and resulted in different influences on
enantioselectivity levels. These other influences are untestable at this stage and beyond the scope of
this report.
3. Materials and Methods
3.1. Chemicals
All starting materials and reagents were purchased from Sigma-Aldrich, Acros Organics and
Tokyo Chemical Industry Co., Ltd. (TCI, Tokyo, Japan) and used without any further purification.
All solvents were of HPLC grade and dried and distilled immediately prior to use. All reactions were
performed using oven dried glassware and flame dried under vacuum prior to use. TLC was performed
using Sigma-Aldrich pre-coated silica gel 60 F254 aluminium support (20 × 20 cm, layer thickness
0.2 mm) and spots were visualized by either using UV light (254 nm). Preparative TLC purifications
were performed using Sigma-Aldrich pre-coated silica gel 60 F254 glass support (20 × 20 cm, 0.25 mm
layer thickness). Column chromatography was carried out on silica gel 60 (130-270 mesh ASTM,
Sigm -Aldrich, St. Louis, MO, USA) using the specified eluent compositions. Rh2(OAc)4 was
purchased from Strem Chemicals (Newburyport, MA, USA).
3.2. Instruments
Melting point were measu ed o Stuart-SMP10 melting point apparatus and are uncorrected.
Optical rotatio s were measur d using Perkin–Elmer 341 polarimeter at the sodium D line (589 nm)
and reported as [α]D25 in g/100 mL concentration (c) and in solvents indicated. IR spectroscopic
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measurements were carried out on PerkinElmer TravelIR FT-IR spectrometer and reported in units
of cm−1. NMR spectra were recorded on Varian 400-MR and Varian Inova-500 spectrometers at
room temperature. Mass Spectrometric analysis was recorded on Finnigen mat LCQ MS/MS ESI
spectrometer and AB MDS Sciex 4800 MALDI-TOF-TOF mass analyser.
3.3. HPLC Analysis
The HPLC analysis was carried out at 25 ◦C using a Prominence Shimadzu System that consists
of LC-20AD solvent delivery unit, SPD-M20A photodiode-array detector, SIL-20AHT auto sampler and
CTO-20A column oven. For data processing, LabSolutions data managing software, version 5.54 SP2
was utilized. Chiralpak® IB (0.46 mm × 250 mm), Chiralpak® IG (0.46 mm × 250 mm) and Chiralpak®
ID (0.46 mm × 250 mm) were obtained from Daicel Chiral Technologies. HPLC-grade n-hexane, ethyl
acetate and 2-propanol were obtained from Scharlau Chemie S.A. (Sentmenat, Barcelona, Spain).
3.4. X-ray Crystallography for Dirhodium(II) Complexes
X-ray quality crystals of the dirhodium(II) complexes were obtained by dissolving the pure
complex in the relevant solvent (for [Rh2(S-PTTL)4(H2O)][Rh2(S-PTTL)4(H2O)2].5H2O green prismatic
crystals from MeOH/water, [Rh2(S,S,S,R-PTTL)4(MeOH)2].MeOH.H2O green plate shaped crystals
from MeOH/water and for [Rh2(S-PTTL)4(MeOH)2].(MeOH)3/2 green prismatic crystals from
anhydrous MeOH). The resulting solutions were subjected to sonication and Pasteur pipette filtration
followed by slow evaporation of the solvent to yield crystals. Data were collected at −173 ◦C
on crystals mounted on a Hampton Scientific cryoloop at the MX1 or MX2 beamlines, Australian
Synchrotron, Victoria [59]. The structures were solved by direct methods with SHELXS-97, refined
using full-matrix least-squares routines against F2 with SHELXL-97 [60], and visualised using
X-SEED [61]. All non-hydrogen atoms were anisotropically refined, while, all hydrogen atoms were
positioned in calculated locations and refined using a riding model with fixed C–H distances of 0.95 Å
(sp2CH), 0.99 Å (CH2), 0.98 Å (CH3). The thermal parameters of all hydrogen atoms were estimated as
Uiso(H) = 1.2Ueq(C) except for CH3 where Uiso(H) = 1.5Ueq(C).
CCDC-1834045-1834047 contain the supplementary crystallographic data for this paper. These
data can be obtained free of charge from The Cambridge Crystallographic Data Centre via https:
//www.ccdc.cam.ac.uk/structures/.
3.5. General Procedure for Ligand Preparation
A mixture of 1,2-naphthalic anhydride (1.1 equiv.) and the L-amino acid (1 equiv.) in either
anhydrous acetic acid, DMF or toluene/TEA (0.1 equiv.) was heated to reflux under nitrogen
atmosphere overnight. After that time, the reaction was worked up according to one of the below
procedures to afford the corresponding reaction product.
3.6. Reaction Workup Procedures
(a) When using acetic acid as solvent
The reaction solvent was evaporated in vacuo and the residue was directly purified on silica gel
column chromatography using ethyl acetate: n-hexane as an eluent to afford the desired product.
(b) When using DMF as solvent
The reaction mixture was diluted in water and extracted with ethyl acetate twice. The organic
layer was washed with water three times, dried over anhydrous Na2SO4, filtered and concentrated
in vacuo. The residue was then purified on silica gel column chromatography using ethyl acetate:
n-hexane as an eluent to afford the desired product.
(c) When using Toluene/TEA as solvent
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The mixture was diluted with ethyl acetate, washed twice with 0.1 M hydrochloric acid solution,
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was then purified
on silica gel column chromatography using ethyl acetate: n-hexane as an eluent to afford the
desired product.
3.7. N-(Phthaloyl)-Tert-Leucine (PTTL)
Phthalic anhydride (0.5 g, 3.38 mmol), L-tert-Leucine (0.402 g, 3.07 mmol); white solid (0.746 g,
93%); mp 154 ◦C. Spectroscopic data were consistent with the previously published literature [53].
Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with
0.1% TFA, 0.25 mL/min, 254 nm, τ1 = 16.0 min, τ2 = 17.0 min.
3.8. N-(1,2-Naphthaloyl)-Tert-Leucine (1,2-NTTL)
1,2-Naphthalic anhydride (0.650 g, 3.28 mmol), L-tert-Leucine (0.391 g, 2.98 mmol); yellow oil
(0.825 g, 89%). Spectroscopic data were consistent with the previously published literature [36].
Conditions for chiral HPLC trace: Chiralpak® IB column, 10% 2-propanol in n-hexane (v/v%) with
0.1% TFA, 0.25 mL/min, 254 nm, τ1 = 22.5 min, τ2 = 24.5 min.
3.9. N-(1,2-Naphthaloyl)-Phenylalanine (1,2-NTPA)
1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Phenylalanine (0.35 g, 2.10 mmol); pale yellow
solid (0.65 g, 89%); mp 182 ◦C. Spectroscopic data were consistent with the previously published
literature [36]. Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane
(v/v%) with 0.1% TFA, 0.5 mL/min, 254 nm, τ1 = 40.0 min, τ2 = 44.0 min.
3.10. N-(1,2-Naphthaloyl)-Leucine (1,2-NTLU)
1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Leucine (0.3 g, 2.29 mmol); pale yellow solid
(0.64 g, 90%); mp 138–139 ◦C. Spectroscopic data were consistent with the previously published
literature [36]. Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane
(v/v%) with 0.1% TFA; 0.25 mL/min, 254 nm, τ1 = 56.0 min, τ2 = 61.0 min.
3.11. N-(1,2-Naphthaloyl)-Tryptophan (1,2-NTTR)
1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Tryptophan (0.47 g, 2.29 mmol); yellow solid
(0.83 g, 85%); mp 238–239 ◦C. Spectroscopic data were consistent with the previously published
literature [36]. Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane
(v/v%) with 0.1% TFA; 0.25 mL/min, 254 nm, τ1 = 110.0 min, τ2 = 131.0 min.
3.12. N-(1,2-Naphthaloyl)-Tyrosine (1,2-NTTY)
1,2-Naphthalic anhydride (0.5 g, 2.52 mmol), L-Tyrosine (0.42 g, 2.29 mmol); yellow solid (0.74 g,
90%); mp 248–249 ◦C. Spectroscopic data were consistent with the previously published literature [36].
Conditions for chiral HPLC trace: Chiralpak® ID column, 10% 2-propanol in n-hexane (v/v%) with
0.1% TFA, 0.5 mL/min, 254 nm, τ1 = 52.5 min, τ2 = 51.0 min.
3.13. General Procedure for Ligand Exchange
A mixture of the prepared carboxylic acid ligand (6 equiv.) and dirhodium(II) tetraacetate
(Rh2(OAc)4, 1 equiv.) in dry chlorobenzene was refluxed for 24 h under nitrogen atmosphere using a
Soxhlet extractor fitted with a thimble containing dry mixture of Na2CO3 and sand (1:1) for trapping
the eliminated acetic acid molecules. After that time, the solvent was evaporated in vacuo and the
residue was re-dissolved in DCM, washed with saturated NaHCO3 solution, dried over anhydrous
Na2SO4, filtered and concentrated in vacuo. The green residue was then purified by means of silica
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gel column chromatography using ethyl acetate: n-hexane as mobile phase. Spectroscopic data of all
prepared complexes were consistent with the previously published literature [36,53].
3.14. General Procedure for Cyclopropanation
2,2-Dimethyl-1,3-dioxane-4,6-dione (1 equiv.) was dissolved in dry dichloromethane and stirred
with (diacetoxy)iodobenzene (1.4 equiv.), aluminium oxide (2.3 equiv.), 4Å molecular sieves and
dirhodium(II) catalyst (0.01 equiv.) under nitrogen atmosphere for 5 min. After that time, Styrene
(10 equiv.) was added and the mixture was stirred for 2 h. The reaction was then terminated by
filtration through Celite® and concentrated in vacuo. The obtained residue was then purified by means
of preparative TLC. Spectroscopic data were consistent with the previously published literature [54,57].
Enantiomeric excess of the cyclopropane product was determined by chiral HPLC analysis. Conditions
for chiral HPLC trace: Chiralpak® IG column, 10% ethyl acetate in n-hexane (v/v%); 1 mL/min,
254 nm, τ1 = 25 min, τ2 = 33 min. Product yields are illustrated in Table 1.
Table 1. Yields for the obtained cyclopropane product.







1 Yields for product obtained from enantiopure complexes.
4. Conclusions
The current report contributes to the structural understanding of the reactivity and selectivity of
dirhodium(II) carboxylate complexes derived from N-protected amino acid ligands. This contribution
was through investigating the effect of ligand stereo-purity on the catalyst enantioselectivity.
In conclusion, the use of partially resolved chiral ligand can produce some perturbations generated
by the formation of diastereomeric complexes and such perturbations cannot be deducted from the
sole behaviour of the catalyst prepared from the enantio-impure ligand. This was confirmed by the
observation of Rh2(S,S,S,R-PTTL)4 diastereomer structure. The complex showed that it adapts an
α,α,α,β- structure in solid state with the three S-ligands pointing to one side while the R-ligand is
alone on the other. By having a partial chiral cavity, the observed complex was anticipated to perform
catalysis in a similar way to its diastereomer Rh2(S-PTTL)4. The obtained catalysis results did show
deviation from linearity and did reflect the anticipated effect caused by the presence of this type of
diastereomer on the enantioselectivity of some dirhodium(II) carboxylate catalysts. In this regard,
further research is currently being carried out in our group aiming for a more systematic study and
endeavouring to get further insights into this interesting topic. Results will be reported in due course.
This report has also heightened awareness of subtle conformational variations that these
complexes can adapt during the various phases of their catalytic cycles. This awareness evolved
through the discovery of new Rh2(S-PTTL)4 structures including its mono- and di-aquated adducts,
as well as its di-methanol adduct.
Generally, by drawing attention to the added complexity of these important structural issues,
we can acknowledge that dirhodium(II) carboxylate catalysts are highly fluxional structures and
more than one catalyst conformation might be present in solution at the same time. The energetics
of these different conformers can change throughout the catalytic process and different conformers
may have different energy barriers in productive processes involved in the catalytic cycle. Hence,
the different conformers of the catalyst will contribute to the overall catalytic process to different
extents proportional to their relative abundance in solution.
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